Boehringer Ingelheim Pharmaceuticals Inc. v. Ipca Laboratories Ltd. - 1:25-cv-01207

Explore the details of the Boehringer Ingelheim Pharmaceuticals Inc. v. Ipca Laboratories Ltd. case under case number 1:25-cv-01207 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-01207
Filing Date
Sep 29, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Ipca Laboratories Ltd. -
Boehringer Ingelheim Pharma GmbH & Co. KG -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries